Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

More articles from Original Article

  • You have access
    Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
    Yubei Huang, Huan Wang, Zhangyan Lyu, Hongji Dai, Peifang Liu, Ying Zhu, Fengju Song and Kexin Chen
    Cancer Biology & Medicine September 2022, 19 (9) 1375-1384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0758
  • You have access
    Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
    Haoran Mu, Dongqing Zuo, Jie Chen, Zhigang Liu, Zhuo Wang, Liu Yang, Qihui Shi and Yingqi Hua
    Cancer Biology & Medicine September 2022, 19 (9) 1397-1409; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0279
  • You have access
    Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer
    Cuicui Zhang, Jing Wang, Xinyue Wang, Zhaoting Meng, Ying Cheng and Kai Li
    Cancer Biology & Medicine August 2022, 19 (8) 1249-1258; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0727
  • You have access
    The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer
    Ting He, Yinglei Gao, Yanfen Fang, Yangming Zhang, Shuwei Zhang, Fajun Nan, Jian Ding and Yi Chen
    Cancer Biology & Medicine August 2022, 19 (8) 1172-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0130
  • You have access
    Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
    Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
    Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
  • You have access
    PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
    Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
    Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
  • You have access
    Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study
    Wenhui Wu, Zongchao Liu, Zhexuan Li, Weidong Liu, Lanfu Zhang, Yang Zhang, Tong Zhou, Weicheng You, Kaifeng Pan and Wenqing Li
    Cancer Biology & Medicine August 2022, 19 (8) 1259-1273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0255
  • You have access
    Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
    Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
    Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585
  • You have access
    Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer
    Ye Tian, Qiang Li and Yuan Pan
    Cancer Biology & Medicine August 2022, 19 (8) 1274-1281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0108
  • You have access
    BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair
    Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang and Qiang Liu
    Cancer Biology & Medicine August 2022, 19 (8) 1150-1171; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0178

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 38

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire